3-(azolylmethoxy)biphenyl derivatives as inhibitors of the pd-1/pd-l1 protein/protein interactionDömling, A., 10-Jan-2019, Patent No. WO2019008154, 6-Jul-2018, Priority date 7-Jul-2017
Research output: Patent › Professional
The present invention provides novel compounds of formula (I) that are useful as inhibitors of the PD-1/PD-L1 protein/protein interaction. The compounds may be used in the treatment of cancer, infectious diseases and neurodegenerative diseases such as schizophrenia, Alzheimer, multiple sclerosis or Parkinson.
|Publication status||Published - 10-Jan-2019|